Meagan Murphy Wasfy, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Athletes | 24 | 2024 | 1162 | 2.630 |
Why?
|
Exercise Test | 9 | 2024 | 2185 | 1.680 |
Why?
|
Oxygen Consumption | 9 | 2024 | 1872 | 1.600 |
Why?
|
Physical Endurance | 8 | 2024 | 368 | 1.530 |
Why?
|
Sports | 7 | 2024 | 699 | 1.350 |
Why?
|
Hypertrophy, Left Ventricular | 5 | 2017 | 855 | 1.260 |
Why?
|
Ventricular Remodeling | 10 | 2022 | 1276 | 1.230 |
Why?
|
Exercise | 14 | 2024 | 5939 | 1.120 |
Why?
|
Running | 4 | 2020 | 488 | 1.080 |
Why?
|
Cardiovascular System | 2 | 2023 | 838 | 0.980 |
Why?
|
Competitive Behavior | 3 | 2020 | 77 | 0.930 |
Why?
|
Exercise Tolerance | 3 | 2022 | 841 | 0.830 |
Why?
|
Football | 6 | 2023 | 504 | 0.760 |
Why?
|
Heart Ventricles | 8 | 2021 | 3833 | 0.730 |
Why?
|
Death, Sudden, Cardiac | 6 | 2024 | 1568 | 0.730 |
Why?
|
Pulmonary Ventilation | 1 | 2023 | 375 | 0.730 |
Why?
|
Adaptation, Physiological | 7 | 2021 | 1310 | 0.700 |
Why?
|
Sports Medicine | 3 | 2024 | 239 | 0.690 |
Why?
|
Electrocardiography | 8 | 2024 | 6409 | 0.650 |
Why?
|
Coronary Occlusion | 1 | 2021 | 284 | 0.610 |
Why?
|
Swimming | 1 | 2019 | 212 | 0.600 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2019 | 1338 | 0.590 |
Why?
|
Coronary Angiography | 6 | 2020 | 4498 | 0.570 |
Why?
|
Pulmonary Gas Exchange | 1 | 2019 | 389 | 0.560 |
Why?
|
Echocardiography | 10 | 2024 | 5041 | 0.540 |
Why?
|
Physical Exertion | 1 | 2019 | 666 | 0.520 |
Why?
|
Heart | 5 | 2023 | 4419 | 0.500 |
Why?
|
Physical Fitness | 4 | 2022 | 743 | 0.490 |
Why?
|
Coronary Vessel Anomalies | 2 | 2016 | 308 | 0.490 |
Why?
|
Ventricular Function, Left | 6 | 2020 | 3930 | 0.490 |
Why?
|
Myocardial Contraction | 3 | 2019 | 1516 | 0.480 |
Why?
|
Naval Medicine | 1 | 2014 | 30 | 0.470 |
Why?
|
Cardiovascular Diseases | 7 | 2024 | 15647 | 0.450 |
Why?
|
Soccer | 3 | 2023 | 142 | 0.440 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2009 | 391 | 0.440 |
Why?
|
Myocarditis | 1 | 2021 | 803 | 0.440 |
Why?
|
Ovary | 2 | 2009 | 961 | 0.430 |
Why?
|
Codon, Nonsense | 1 | 2014 | 288 | 0.400 |
Why?
|
Tachycardia, Supraventricular | 1 | 2015 | 272 | 0.400 |
Why?
|
Myosins | 1 | 2014 | 408 | 0.400 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2014 | 203 | 0.400 |
Why?
|
Syncope | 1 | 2015 | 431 | 0.390 |
Why?
|
Coronary Artery Disease | 4 | 2021 | 6544 | 0.380 |
Why?
|
Puberty | 1 | 2014 | 495 | 0.370 |
Why?
|
Echocardiography, Doppler | 4 | 2019 | 899 | 0.340 |
Why?
|
Retinal Degeneration | 1 | 2014 | 413 | 0.330 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1121 | 0.330 |
Why?
|
Chest Pain | 1 | 2015 | 1102 | 0.300 |
Why?
|
Tomography, X-Ray Computed | 7 | 2024 | 20700 | 0.290 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1017 | 0.290 |
Why?
|
Atrial Fibrillation | 2 | 2022 | 5185 | 0.270 |
Why?
|
Energy Metabolism | 1 | 2017 | 2894 | 0.270 |
Why?
|
Coronary Stenosis | 1 | 2012 | 798 | 0.250 |
Why?
|
Humans | 58 | 2024 | 766117 | 0.240 |
Why?
|
Myocardium | 1 | 2017 | 4766 | 0.230 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2255 | 0.230 |
Why?
|
Stroke Volume | 5 | 2021 | 5595 | 0.210 |
Why?
|
Zebrafish | 1 | 2014 | 3035 | 0.200 |
Why?
|
Longitudinal Studies | 9 | 2022 | 14747 | 0.200 |
Why?
|
Pulse | 1 | 2021 | 217 | 0.190 |
Why?
|
Risk Assessment | 5 | 2020 | 24276 | 0.180 |
Why?
|
Shoes | 1 | 2020 | 90 | 0.170 |
Why?
|
Male | 29 | 2024 | 363935 | 0.170 |
Why?
|
Prospective Studies | 11 | 2022 | 54812 | 0.170 |
Why?
|
Blood Pressure | 4 | 2021 | 8532 | 0.170 |
Why?
|
Heart Failure | 2 | 2024 | 11837 | 0.160 |
Why?
|
Heart Diseases | 3 | 2021 | 2818 | 0.160 |
Why?
|
Hospitals, General | 2 | 2016 | 803 | 0.160 |
Why?
|
Nutritional Requirements | 1 | 2020 | 276 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11509 | 0.150 |
Why?
|
Female | 26 | 2024 | 396233 | 0.150 |
Why?
|
Body Size | 1 | 2020 | 460 | 0.140 |
Why?
|
Risk Factors | 10 | 2024 | 74857 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15403 | 0.140 |
Why?
|
Postpartum Period | 1 | 2024 | 1195 | 0.140 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 848 | 0.140 |
Why?
|
Cardiac Output | 1 | 2019 | 838 | 0.140 |
Why?
|
Osteoarthritis, Hip | 1 | 2021 | 408 | 0.130 |
Why?
|
Foot | 1 | 2020 | 576 | 0.130 |
Why?
|
Hand Strength | 1 | 2019 | 464 | 0.130 |
Why?
|
Blood Volume | 1 | 2017 | 544 | 0.130 |
Why?
|
Norepinephrine | 1 | 2019 | 898 | 0.130 |
Why?
|
Muscle Strength | 1 | 2020 | 638 | 0.130 |
Why?
|
Pressure | 1 | 2019 | 1171 | 0.130 |
Why?
|
Exercise Therapy | 2 | 2023 | 938 | 0.130 |
Why?
|
Physical Examination | 1 | 2022 | 1263 | 0.130 |
Why?
|
Stress, Mechanical | 1 | 2020 | 1670 | 0.120 |
Why?
|
Epinephrine | 1 | 2019 | 782 | 0.120 |
Why?
|
Adult | 18 | 2024 | 223139 | 0.120 |
Why?
|
Middle Aged | 18 | 2024 | 223083 | 0.120 |
Why?
|
Androgen Antagonists | 1 | 2024 | 1411 | 0.120 |
Why?
|
Menstrual Cycle | 2 | 2009 | 539 | 0.120 |
Why?
|
Ships | 1 | 2014 | 53 | 0.120 |
Why?
|
Nystagmus, Optokinetic | 1 | 2014 | 31 | 0.110 |
Why?
|
Melanosomes | 1 | 2014 | 34 | 0.110 |
Why?
|
Aortic Diseases | 1 | 2020 | 741 | 0.110 |
Why?
|
Rod Opsins | 1 | 2014 | 108 | 0.110 |
Why?
|
Usher Syndromes | 1 | 2014 | 56 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 26290 | 0.100 |
Why?
|
Dark Adaptation | 1 | 2014 | 223 | 0.100 |
Why?
|
In Situ Nick-End Labeling | 1 | 2014 | 610 | 0.100 |
Why?
|
Preventive Health Services | 1 | 2017 | 571 | 0.100 |
Why?
|
Adolescent | 8 | 2021 | 88819 | 0.100 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2014 | 204 | 0.100 |
Why?
|
Athletic Injuries | 1 | 2023 | 1244 | 0.100 |
Why?
|
Aorta | 1 | 2020 | 2040 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 683 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8725 | 0.100 |
Why?
|
Electroretinography | 1 | 2014 | 522 | 0.100 |
Why?
|
Radiation Dosage | 1 | 2010 | 1945 | 0.100 |
Why?
|
Brain Injuries | 1 | 2023 | 2062 | 0.090 |
Why?
|
Young Adult | 8 | 2021 | 59868 | 0.090 |
Why?
|
Brain Concussion | 1 | 2023 | 1432 | 0.090 |
Why?
|
Medical History Taking | 1 | 2015 | 779 | 0.090 |
Why?
|
Cardiology | 2 | 2024 | 1696 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3432 | 0.090 |
Why?
|
Aging | 1 | 2009 | 8723 | 0.090 |
Why?
|
Heart Rate | 2 | 2019 | 4204 | 0.090 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1248 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1414 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2010 | 3617 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1378 | 0.090 |
Why?
|
Prognosis | 5 | 2024 | 29912 | 0.090 |
Why?
|
Bone and Bones | 1 | 2020 | 2555 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12976 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10614 | 0.080 |
Why?
|
Body Weight | 2 | 2016 | 4626 | 0.080 |
Why?
|
Aged | 9 | 2024 | 171219 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.080 |
Why?
|
Animals, Genetically Modified | 1 | 2014 | 1563 | 0.080 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1464 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3407 | 0.080 |
Why?
|
Cell Death | 1 | 2014 | 1676 | 0.080 |
Why?
|
Unnecessary Procedures | 1 | 2012 | 412 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2015 | 1093 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 40108 | 0.070 |
Why?
|
Myopia, Degenerative | 1 | 2007 | 13 | 0.070 |
Why?
|
Light | 1 | 2014 | 1358 | 0.070 |
Why?
|
Aortic Valve | 1 | 2017 | 1964 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2016 | 1161 | 0.070 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15882 | 0.070 |
Why?
|
Body Mass Index | 2 | 2020 | 13046 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2017 | 2136 | 0.070 |
Why?
|
Probability | 1 | 2012 | 2475 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5450 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6545 | 0.060 |
Why?
|
Waist Circumference | 1 | 2009 | 934 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2009 | 706 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3316 | 0.060 |
Why?
|
Patient Selection | 2 | 2012 | 4249 | 0.060 |
Why?
|
Waist-Hip Ratio | 1 | 2006 | 521 | 0.060 |
Why?
|
Anthropometry | 1 | 2009 | 1339 | 0.060 |
Why?
|
Boston | 2 | 2012 | 9335 | 0.060 |
Why?
|
Choroidal Neovascularization | 1 | 2007 | 350 | 0.060 |
Why?
|
Follicle Stimulating Hormone | 1 | 2006 | 731 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2014 | 2646 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13468 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18386 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4086 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6604 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6421 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2235 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11094 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41684 | 0.050 |
Why?
|
Photochemotherapy | 1 | 2007 | 826 | 0.050 |
Why?
|
Technology | 1 | 2023 | 296 | 0.040 |
Why?
|
Respiratory Rate | 1 | 2022 | 179 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11035 | 0.040 |
Why?
|
Hypertension | 2 | 2019 | 8616 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2024 | 422 | 0.040 |
Why?
|
Gorilla gorilla | 1 | 2019 | 29 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22228 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2019 | 224 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39243 | 0.040 |
Why?
|
United States | 6 | 2023 | 72920 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2020 | 1006 | 0.040 |
Why?
|
Incidence | 1 | 2016 | 21513 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14645 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2406 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18321 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7424 | 0.030 |
Why?
|
Systole | 1 | 2016 | 935 | 0.030 |
Why?
|
Observer Variation | 1 | 2010 | 2611 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1225 | 0.030 |
Why?
|
Aortic Valve Insufficiency | 1 | 2017 | 575 | 0.030 |
Why?
|
Neural Pathways | 1 | 2024 | 3079 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2024 | 1878 | 0.030 |
Why?
|
Child | 1 | 2020 | 80573 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20137 | 0.020 |
Why?
|
Algorithms | 1 | 2012 | 14066 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3202 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4247 | 0.020 |
Why?
|
Hemodynamics | 1 | 2019 | 4188 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8724 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2017 | 1563 | 0.020 |
Why?
|
Fovea Centralis | 1 | 2007 | 121 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168800 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 1306 | 0.020 |
Why?
|
Retreatment | 1 | 2007 | 598 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8347 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2504 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10087 | 0.010 |
Why?
|
Curriculum | 1 | 2017 | 3784 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15827 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8882 | 0.010 |
Why?
|
Quality Improvement | 1 | 2017 | 3849 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30233 | 0.010 |
Why?
|
Clinical Competence | 1 | 2017 | 4859 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16716 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5367 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13616 | 0.010 |
Why?
|
Visual Acuity | 1 | 2007 | 2672 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36548 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2017 | 81565 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 65219 | 0.000 |
Why?
|